Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death.

作者: Hyun-Jung Moon , Hak-Bong Kim , Su-Hoon Lee , So-Eun Jeun , Chi-Dug Kang

DOI: 10.18632/ONCOTARGET.24130

关键词: Multiple drug resistanceChemistryCancer researchHeat shock proteinPI3K/AKT/mTOR pathwayHsp90 inhibitorProgrammed cell deathApoptosisCancer cellAutophagy

摘要: NSAIDs (non-steroidal anti-inflammatory drugs) have potential use as anticancer agents, either alone or in combination with other cancer therapies. We found that including celecoxib (CCB) and ibuprofen (IBU) significantly potentiated the cytotoxicity of Hsp90 inhibitors human multidrug-resistant (MDR) cells expressing high levels mutant p53 (mutp53) protein P-glycoprotein (P-gp), reversed inhibitor resistance caused by activation heat shock factor 1 (HSF1) up-regulation proteins (Hsps) P-gp. Inhibition Akt/mTOR STAT3 pathways CCB induced autophagy, which promoted degradation mutp53, one client proteins, subsequently down-regulated HSF1/Hsps autophagy prevented mutp53 CCB-induced apoptosis, inhibition caspase-3-mediated apoptotic pathway Z-DEVD-FMK did not completely block cell death MDR cells, suggesting autophagic may contribute to cells. Furthermore, IBU suppressed inhibitor-induced HSF1/Hsp70/P-gp activity expression Our results suggest can be used chemosensitizers reverse via induction apoptosis autophagy. These might enable lower, less toxic doses facilitate design practically applicable, novel therapy for treatment cancer.

参考文章(46)
Katrina S. Pedersen, George P. Kim, Nathan R. Foster, Andrea Wang-Gillam, Charles Erlichman, Robert R. McWilliams, Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study Investigational New Drugs. ,vol. 33, pp. 963- 968 ,(2015) , 10.1007/S10637-015-0246-2
Federico Díaz-González, Francisco Sánchez-Madrid, NSAIDs: Learning new tricks from old drugs European Journal of Immunology. ,vol. 45, pp. 679- 686 ,(2015) , 10.1002/EJI.201445222
Rabia Bushra, Nousheen Aslam, An overview of clinical pharmacology of Ibuprofen. Oman Medical Journal. ,vol. 25, pp. 155- 1661 ,(2010) , 10.5001/OMJ.2010.49
Marisa Granato, Barbara Chiozzi, Maria Rosaria Filardi, Lavinia Vittoria Lotti, Livia Di Renzo, Alberto Faggioni, Mara Cirone, Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells. Cancer Letters. ,vol. 366, pp. 191- 197 ,(2015) , 10.1016/J.CANLET.2015.07.006
Afraa Zrieki, Robert Farinotti, Marion Buyse, Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo. European Journal of Pharmacology. ,vol. 636, pp. 189- 197 ,(2010) , 10.1016/J.EJPHAR.2010.03.039
Hong Zhang, Laura Neely, Karen Lundgren, Yong-Ching Yang, Rachel Lough, Noel Timple, Francis Burrows, BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance International Journal of Cancer. ,vol. 126, pp. 1226- 1234 ,(2009) , 10.1002/IJC.24825
Evguenia M. Alexandrova, Natalia D. Marchenko, Mutant p53 – Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival Frontiers in Endocrinology. ,vol. 6, pp. 53- 53 ,(2015) , 10.3389/FENDO.2015.00053
Dong-bo Liu, Guang-yuan Hu, Guo-xian Long, Hong Qiu, Qi Mei, Guo-qing Hu, Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation Acta Pharmacologica Sinica. ,vol. 33, pp. 682- 690 ,(2012) , 10.1038/APS.2012.18
Giampietro Viola, Roberta Bortolozzi, Ernest Hamel, Stefano Moro, Paola Brun, Ignazio Castagliuolo, Maria Grazia Ferlin, Giuseppe Basso, MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells. Biochemical Pharmacology. ,vol. 83, pp. 16- 26 ,(2012) , 10.1016/J.BCP.2011.09.017
Peter W. Piper, Stefan H. Millson, Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges. Pharmaceuticals. ,vol. 4, pp. 1400- 1422 ,(2011) , 10.3390/PH4111400